Expertise in
2
conditions

Yen-cheng M. Chiu

138 Sheng Li Road, 
Tainan, TNQ, TW 
Expertise in
2
conditions
138 Sheng Li Road, 
Tainan, TNQ, TW 

Overview

Yen-cheng Chiu practices practicing medicine in Tainan, Taiwan.

Chiu is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Hepatitis, Hepatitis C, Hepatitis B, and Liver Cancer.

They are actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 2 clinical trials.

Locations

138 Sheng Li Road, Tainan, TNQ 70401, Taiwan
Other Locations
Hsinchu, TNQ 30013, Taiwan
Taitung, TNQ, Taiwan
Dawan, TNQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Atezolizumab Plus Bevacizumab for Patients With Advanced Hepatocellular Carcinoma (HCC) and Chronic Hepatitis B Virus (HBV) Infection
Atezolizumab Plus Bevacizumab for Patients With Advanced Hepatocellular Carcinoma (HCC) and Chronic Hepatitis B Virus (HBV) Infection
Enrollment Status: Active_not_recruiting
Publish Date: April 09, 2026
Intervention Type: Drug
Study Phase: Not Applicable
Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir for Treatment-Naive and Treatment-Experienced Non-Cirrhotic Patients With Hepatitis C Virus Genotype 1b Receiving Hemodialysis
Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir for Treatment-Naive and Treatment-Experienced Non-Cirrhotic Patients With Hepatitis C Virus Genotype 1b Receiving Hemodialysis
Enrollment Status: Completed
Publish Date: July 19, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

51 Total Publications

Correction: Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction‑Associated Fatty Liver Disease (MASLD).
Correction: Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction‑Associated Fatty Liver Disease (MASLD).
Journal: Digestive diseases and sciences
Published: August 29, 2026

Frequently Asked Questions about Yen-cheng M. Chiu

Is Yen-cheng M. Chiu a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Yen-cheng M. Chiu is classified as an Advanced expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yen-cheng M. Chiu participate in research or clinical trials?

Yes. Yen-cheng M. Chiu has published 51 articles and abstracts on conditions like Hepatitis. You can view a list of Yen-cheng M. Chiu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chiu's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile